These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6315603

  • 1. Decreased natural killer activity in patients with liver cirrhosis.
    Nakamura T, Morizane T, Watanabe T, Tsuchimoto K, Inagaki Y, Kumagai N, Tsuchiya M.
    Int J Cancer; 1983 Nov 15; 32(5):573-5. PubMed ID: 6315603
    [Abstract] [Full Text] [Related]

  • 2. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
    Nakajima T, Mizushima N, Kanai K.
    Jpn J Clin Oncol; 1987 Dec 15; 17(4):327-32. PubMed ID: 2826847
    [Abstract] [Full Text] [Related]

  • 3. Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma.
    Morizane T, Watanabe T, Tsuchimoto K, Tsuchiya M.
    Gastroenterol Jpn; 1980 Dec 15; 15(3):226-32. PubMed ID: 6249691
    [Abstract] [Full Text] [Related]

  • 4. Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.
    Wada T, Arima T, Nagashima H.
    Gastroenterol Jpn; 1987 Jun 15; 22(3):312-21. PubMed ID: 3040509
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage.
    Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, Wang LY.
    Dig Dis Sci; 1991 Mar 15; 36(3):299-302. PubMed ID: 1995265
    [Abstract] [Full Text] [Related]

  • 6. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion.
    Chuang WL, Liu HW, Chang WY.
    Cancer; 1990 Feb 15; 65(4):926-30. PubMed ID: 2153437
    [Abstract] [Full Text] [Related]

  • 7. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H.
    Clin Exp Immunol; 1987 May 15; 68(2):348-56. PubMed ID: 2820634
    [Abstract] [Full Text] [Related]

  • 8. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
    Takagi H, Sakurai S, Uehara M, Yamada S, Kobayashi S.
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct 20; 24(10):2369-74. PubMed ID: 2559127
    [Abstract] [Full Text] [Related]

  • 9. [Hepatocarcinoma and killer cell activity].
    Lucea D, Vargas V, Español T, Castells L, Sauleda S, Esteban R, Guardia J.
    Med Clin (Barc); 1995 Sep 30; 105(10):370-3. PubMed ID: 7475439
    [Abstract] [Full Text] [Related]

  • 10. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
    Akagi G, Furuya K, Kanamura A, Chihara T, Otsuka H.
    Cancer; 1984 Jul 15; 54(2):315-8. PubMed ID: 6202391
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.
    Sundaram C, Reddy CR, Ramana GV, Benerjea S, Venkataratnam G, Kumari GS, Reddy BS, Bhaskaran CS.
    Indian J Pathol Microbiol; 1990 Oct 15; 33(4):334-8. PubMed ID: 1966741
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
    Akagi G, Furuya K, Otsuka H.
    Cancer; 1982 Feb 15; 49(4):678-82. PubMed ID: 6275977
    [Abstract] [Full Text] [Related]

  • 13. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.
    Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R.
    Lancet; 1985 Jun 15; 1(8442):1357-60. PubMed ID: 2861313
    [Abstract] [Full Text] [Related]

  • 14. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A, Cordova C, Barnaba V, Bonavita MS, Levrero M, Zaccari C, Balsano F.
    Hepatogastroenterology; 1983 Feb 15; 30(1):3-5. PubMed ID: 6299916
    [Abstract] [Full Text] [Related]

  • 15. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 15; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 16. Killer cell (K-cell) population in chronic liver disease.
    Morimoto T, Okita K, Nishioka M, Takemoto T.
    Gastroenterol Jpn; 1981 Apr 15; 16(4):358-62. PubMed ID: 6269941
    [Abstract] [Full Text] [Related]

  • 17. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 15; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.
    Johnson PJ, Krasner N, Portmann B, Eddleston AL, Williams R.
    Gut; 1978 Nov 15; 19(11):1022-6. PubMed ID: 215496
    [Abstract] [Full Text] [Related]

  • 19. Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma.
    Saibara T, Onishi S, Sakaeda H, Yamamoto Y.
    Hepatology; 1989 Mar 15; 9(3):471-6. PubMed ID: 2537790
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
    Kakumu S, Hirofuji H, Fuji A, Tahara H, Yoshioka K.
    J Clin Lab Immunol; 1988 May 15; 26(1):29-32. PubMed ID: 2846843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.